[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100643809":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":32,"centralContacts":36,"locations":42,"responsibleParty":58,"collaborators":61,"id":65,"slug":66,"hasResults":67,"nctId":68,"briefTitle":69,"officialTitle":70,"acronym":26,"eligibilityCriteria":71,"healthyVolunteers":67,"sex":72,"minAge":73,"maxAge":74,"enrollmentInfo":75,"targetDuration":26,"studyType":78,"phases":79,"briefSummary":81,"conditions":82,"keywords":26,"overallStatus":85,"whyStopped":26,"lastUpdateSubmitDate":86,"lastUpdatePostDateStruct":87,"startDateStruct":90,"completionDateStruct":92,"leadSponsor":94,"locationsCount":95},{"fullName":5,"class":6},"University of Miami","OTHER",[8,15],{"label":9,"type":10,"description":11,"interventionNames":12},"Standard of Care (Tadalafil) + Eroxon® Gel Group","EXPERIMENTAL","Participants assigned to this arm will continue to use tadalafil as prescribed per standard of care treatment and will also be instructed to use Eroxon® gel prior to each sexual encounter throughout the 12-week study period.",[13,14],"Device: Eroxon®","Drug: tadalafil",{"label":16,"type":17,"description":18,"interventionNames":19},"Tadalafil (Control) Group","ACTIVE_COMPARATOR","Participants assigned to this arm will continue their standard-of-care treatment with tadalafil as prescribed. No study-specific changes will be made to their routine clinical management.",[14],[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DEVICE","Eroxon®","Participants will receive a 12-week supply of Eroxon® and will be instructed to apply the gel prior to each sexual encounter as directed at enrollment.",[9],null,{"type":28,"name":29,"description":30,"armGroupLabels":31,"otherNames":26},"DRUG","tadalafil","Tadalafil is administered as standard of care at dose and schedule determined by the treating clinician.",[9,16],[33],{"name":34,"affiliation":5,"role":35},"Sonjia Kenya, E.D","PRINCIPAL_INVESTIGATOR",[37],{"name":38,"role":39,"phone":40,"phoneExt":26,"email":41},"Ashley Gray","CONTACT","786-909-3719","ajg2940@med.miami.edu",[43],{"facility":44,"status":26,"city":45,"state":46,"zip":47,"country":48,"countryCode":49,"cosmosGeoPoint":50,"geoPoint":55,"contacts":56},"Don Soffer Clinical Research Building","Miami","Florida","33136","United States","US",{"type":51,"coordinates":52},"Point",[53,54],-80.19366,25.77427,{"lat":54,"lon":53},[57],{"name":38,"role":39,"phone":40,"phoneExt":26,"email":41},{"type":35,"investigatorFullName":59,"investigatorTitle":60,"investigatorAffiliation":5,"oldNameTitle":26,"oldOrganization":26},"Sonjia Kenya","Professor of Professional Practice",[62],{"name":63,"class":64},"Sexual Medicine Society of North America Inc.","UNKNOWN","100643809","phase-4-pleasure-pleasing-lovers-efficacy-arousal-satisfaction-and-uptake-research-on-eroxon-100643809",false,"NCT07636161","PLEASURE (Pleasing Lovers, Efficacy, Arousal, Satisfaction, and Uptake Research on Eroxon)","PLEASURE (Pleasing Lovers, Efficacy, Arousal, Satisfaction, and Uptake Research on Eroxon): A Pilot Randomized Trial of Eroxon® Gel as an Adjunct to Tadalafil in Young Men With Diabetes-Associated Erectile Dysfunction","Inclusion Criteria:\n\n* Male sex at birth\n* Age 18-40 years\n* Diagnosis of type 2 diabetes mellitus\n* Diagnosis of erectile dysfunction\n* Currently prescribed tadalafil\n* Have a sexual partner willing to complete a survey\n* Ability to provide informed consent\n\nExclusion Criteria:\n\n* Type 1 diabetes mellitus\n* Severe psychiatric illness that would impair participation\n* Use of nitrates or contraindications to sexual activity\n* Known allergy to Eroxon® gel components\n* Participation in another interventional sexual health study","MALE","18 Years","40 Years",{"count":76,"type":77},30,"ESTIMATED","INTERVENTIONAL",[80],"PHASE4","The purpose of this research study is to look at whether Eroxon® gel when used together with tadalafil, may help improve erectile function in men ages 18 to 40 who have type 2 diabetes.",[83,84],"Type 2 Diabetes","Type 2 Diabetes (T2DM)","NOT_YET_RECRUITING","2026-06-03",{"date":88,"type":89},"2026-06-09","ACTUAL",{"date":91,"type":77},"2026-09",{"date":93,"type":77},"2027-09",{"name":5,"class":6},1]